Evelo Biosciences News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

17.10.23	Evelo Biosciences: EDP2939-101 Study Fails To Meet Endpoint; To Explore Strategic Alternatives (RTTNews)
16.12.22	Evelo Biosciences Signs With Horizon For $45 Mln Loan (RTTNews)
11.08.22	Evelo Biosciences Q2 Loss Narrows; Announces CEO Transition (RTTNews)
18.07.22	Evelo Biosciences Appoints Marella Thorell As CFO (RTTNews)
25.03.22	ETNB To Report ENTRIGUE Data In Q2, MDVL's Q1 Revenue To More Than Double, OCUP On Watch (RTTNews)
15.02.22	INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANT (PR Newswire)
13.10.21	Invaio Sciences Secures $50 Million Debt Financing to Develop and Commercialize Agricultural Solutions to Address Climate Change (PR Newswire)
27.09.21	Evelo Biosciences Announces Positive Phase 2 Clinical Data With EDP1815 In Psoriasis (RTTNews)
27.09.21	Evelo Biosciences Announces Positive Phase 2 Clinical Data with EDP1815 in Psoriasis; Confirms Ability to Harness the Small Intestinal Axis, SINTAX™, to Treat Systemic Inflammatory Disease (GlobeNewswire)
29.04.21	Evelo Biosciences Reports First Quarter 2021 Financial Results and Business Highlights (GlobeNewswire)
22.04.21	Evelo Biosciences to Report First Quarter 2021 Financial Results on Thursday, April 29, 2021 (GlobeNewswire)
20.04.21	Evelo Biosciences Presents Further Positive Data from Phase 1b Clinical Trial of EDP1815 in Atopic Dermatitis (GlobeNewswire)
15.04.21	Evelo Biosciences Announces Appointments of Luca Scavo as Chief Financial Officer and Julie H. McHugh to the Board of Directors (GlobeNewswire)
05.04.21	Evelo Biosciences to Present at 20th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
23.03.21	Evelo Biosciences & Abdul Latif Jameel Health Announce Strategic Collaboration to Develop & Commercialize Novel Therapy EDP1815 for Inflammatory Diseases & COVID-19 in Select Developing Markets Servin (GlobeNewswire)
09.03.21	Evelo Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results and Business Highlights (GlobeNewswire)
02.03.21	Evelo Biosciences to Report Fourth Quarter and Full Year 2020 Financial Results on Tuesday, March 9, 2021 (GlobeNewswire)
16.02.21	Evelo Biosciences Appoints John A. Hohneker, M.D. to Board of Directors (GlobeNewswire)
29.01.21	Evelo Biosciences Announces Pricing of Public Offering of Common Stock (GlobeNewswire)
28.01.21	Evelo Biosciences Announces Proposed Public Offering of Common Stock (GlobeNewswire)
20.01.21	Evelo Biosciences Reports New Positive Confirmatory Data from Phase 1b Trial of EDP1815 in Atopic Dermatitis (GlobeNewswire)
07.01.21	Evelo Biosciences Expands Clinical Programs and Provides 2021 Guidance on Key Milestones (GlobeNewswire)
28.12.20	Biotech Stock Picks That Delivered Triple-digit Gains - Is There More Room To Run? (RTTNews)
21.12.20	Evelo Biosciences Appoints Industry Veteran Jonathan Zung, Ph.D. as Chief Development Officer (GlobeNewswire)
14.12.20	Stock Alert: Evelo Biosciences Jumps 43% (RTTNews)
09.12.20	Evelo Biosciences Announces New Clinical Candidate in Oncology and Presents Additional Interim Data from Phase 1/2 Clinical Trial of EDP1503 in Patients with Triple-Negative Breast Cancer (GlobeNewswire)
09.12.20	Evelo Biosciences Reports Positive Topline Clinical Data in Phase 1b Trial of EDP1815 in Atopic Dermatitis (GlobeNewswire)
03.12.20	Evelo Biosciences Completes Enrollment to Interim Target in Phase 2 Trial Evaluating EDP1815 for the Treatment of Psoriasis (GlobeNewswire)
09.11.20	Evelo Biosciences Presents New Preclinical Data for Anti-Tumor Effects of Orally Delivered Microbial Extracellular Vesicles at the SITC 35th Anniversary Annual Meeting (GlobeNewswire)
29.10.20	Evelo Biosciences Reports Third Quarter 2020 Financial Results and Business Highlights (GlobeNewswire)
22.10.20	Evelo Biosciences to Report Third Quarter 2020 Financial Results on Thursday, October 29, 2020 (GlobeNewswire)
15.10.20	Evelo Biosciences to Host Key Opinion Leader Discussion Focused on the Unmet Need in Psoriasis and Atopic Dermatitis and the Potential Opportunity for EDP1815 (GlobeNewswire)
14.10.20	Evelo Biosciences Completes Enrollment in Phase 1b Clinical Trial Cohort Evaluating EDP1815 in Atopic Dermatitis (GlobeNewswire)
13.10.20	Evelo Biosciences Treats First Patients in Phase 2 Dose-Ranging Trial of EDP1815 for the Treatment of Psoriasis (GlobeNewswire)
14.09.20	Evelo Biosciences Appoints Julie Carretero as Chief People Officer (GlobeNewswire)
08.09.20	Evelo Biosciences to Participate in Upcoming Investor Conferences in September (GlobeNewswire)
30.07.20	Evelo Biosciences Reports Second Quarter 2020 Financial Results and Business Highlights (GlobeNewswire)
23.07.20	Evelo Biosciences to Report Second Quarter 2020 Financial Results on Thursday, July 30, 2020 (GlobeNewswire)
02.07.20	LMNL Joins COVID-19 Battle, PFE/BNTX Vaccine Data Promising, EVLO On Watch (RTTNews)
01.07.20	Evelo Biosciences to Present Clinical Data from Phase 1/2 Trial of EDP1503 at the ESMO World Congress on Gastrointestinal Cancer Virtual Meeting (GlobeNewswire)
25.06.20	Evelo Biosciences Announces Pricing of Public Offering of Common Stock (GlobeNewswire)
24.06.20	Evelo Biosciences Announces Proposed Public Offering of Common Stock (GlobeNewswire)
23.06.20	MYOV To Report SPIRIT 1 Data, EVLO Joins COVID-19 Drug Race, NVTA Loosens Purse Strings (RTTNews)
22.06.20	Evelo Biosciences Says Experimental EDP1815 To Include In TACTIC-E COVID-19 Trial (RTTNews)
22.06.20	Evelo Biosciences Announces EDP1815 to Advance into Phase 2/3 TACTIC-E COVID-19 Trial (GlobeNewswire)
16.06.20	Evelo Biosciences to Present at Virtual BMO 2020 Prescriptions for Success Healthcare Conference (GlobeNewswire)
28.05.20	Evelo Biosciences to Present at Jefferies Virtual Healthcare Conference (GlobeNewswire)
11.05.20	Evelo Biosciences Reports First Quarter Financial Results and Business Highlights (GlobeNewswire)
07.05.20	Evelo Biosciences, Rutgers University, and Robert Wood Johnson University Hospital Announce Submission of IND for a Phase 2 Study of EDP1815 in COVID-19 Patients (GlobeNewswire)
19.02.20	Evelo Biosciences (EVLO) Building Momentum (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Swisscom	527.00	2.33 %	K V
Holcim	95.34	1.21 %	K V
UBS Group	30.42	0.86 %	K V
Roche Hldg G	289.00	0.45 %	K V
Swiss Re	141.65	0.35 %	K V
Givaudan	3’850.00	-1.48 %	K V
Lonza Grp	603.80	-1.50 %	K V
Alcon	82.30	-1.53 %	K V
Geberit	508.00	-1.74 %	K V
Part Grp Hldg	1’386.00	-2.26 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Evelo Biosciences Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten